New award for trifluoperazine tablets with sandoz, INC. Ordering period is january 14, 2023 to january 13, 2024 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79722D0033
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order 95% complete
IDV ceiling
$236,745.90
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Sandoz Inc. for trifluoperazine tablets with a contract ceiling of $236,745.90 on January 14, 2023. The contract has an ordering period of January 14, 2023 through January 13, 2024, followed by four one-year options, with ultimate completion on January 13, 2027. Sandoz Inc. supplies pharmaceutical products through the VA's prime vendor program to VA medical centers, the Department of Defense, the Bureau of Prisons, and Indian Health Services facilities. The award implements Executive Order 14398 regarding diversity, equity, and inclusion. The presolicitation opportunity was posted on June 30, 2022 with a due date of July 20, 2022.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00011 · Implementing EO 14398 DEI discrimination $0
Add Subcontract Plan P00010 · This modification is issued to incorporate sandoz INC. 2026 subcontracting plan into NC 36E79722D0033. $0
Exercise an Option P00009 · This modification is issued to exercise the 3RD option year for trifluoperazine tablets under contract 36E79722D0033. $0
Add Subcontract Plan P00008 · This modification is issued to incorporate sandoz INC. 2025 subcontracting plan effective for the period of january 1, 2025 -- december 31, 2025. $0
Exercise an Option P00007 · This modification is issued to exercise option year 2 for NC 36E79722D0033 with sandoz, INC. For the period of 1/14/2025 - 1/13/2026. $0
Supplemental Agreement for work within scope P00006 · This modification is issued to update the terms of the CRF payment remittal and submission of quarterly sales reports. $0
Other Administrative Action P00005 · This modification is issued to incorporate a change in the administration and sales point of contact for sandoz, INC. $0
Add Subcontract Plan P00004 · This modification is issued to incorporate sandoz INC. 2024 subcontracting plan. $0
Exercise an Option P00003 · This modification is issued to exercise the 1ST option year for trifluoperazine tablets under contract 36E79722D0033 with sandoz, INC., for the period of… $0
Other Administrative Action P00002 · This modification is issued to incorporate the drug supply chain security act (DSCSA) language into the contract. $0
Add Subcontract Plan P00001 · This modification is issued to incorporate sandoz INC. 2023 subcontracting plan effective for the period of january 1, 2023 -- december 31, 2023. The plan is… $0
Original award $0
Show all 12

Quick answers

Who was awarded contract 36E79722D0033?

36E79722D0033 was awarded to Sandoz Inc. by National Acquisition Center (Headquarters) on January 14, 2023.

How much is contract 36E79722D0033 worth?

36E79722D0033's own ceiling is $236,746.

Who can order from contract 36E79722D0033?

36E79722D0033 is a single award indefinite delivery contract.

Was contract 36E79722D0033 competed?

The extent of competition for 36E79722D0033 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV